Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,22118,240 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

Project Summary Understanding the role of TP53 mutation in genetic susceptibility to ovarian cancer Women with germline mutations in BRCA1 and BRCA2 (BRCA carriers) are at high ris...

$5.17M
USD
Completed OTHER RESEARCH-RELATED
Developing novel CAR T cell designs using combinatorial antigen detection
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Candidate: The applicant, Greg Allen, MD/PhD, is a medical oncologist at UCSF with a long-term goal to lead an independent laboratory-based translational r...

$2.87M
USD
Completed NON-SBIR/STTR RPGS
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Sarcomatoid renal cell carcinoma (sRCC) represents an aggressive group of renal epithelial tumors characterized by histopathological features of epithelial–mesenchymal plasticity (...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
Defining the role of BARD1 in nucleosomal ubiquitylation
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

PROJECT SUMMARY BARD1 (BRCA1-Associated RING Domain protein-1) is an essential partner of the breast and ovarian cancer tumor-suppressor protein, BRCA1, and is included in a panel...

$5.27M
USD
Completed NON-SBIR/STTR RPGS
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
NATIONAL CANCER INSTITUTE University of Maryland, College Park United States 2021 – 2026

ABSTRACT The prognosis for patients with advanced stage ovarian or pancreatic cancer has remained dismal for decades. The poor response rates result, in part, from resistance to sa...

$6.59M
USD
Completed NON-SBIR/STTR RPGS
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

PROJECT SUMMARY Ovarian cancer is a silent killer that strikes with few, if any, symptoms. By the time a woman knows she has it, the cancer is often advanced and the outlook grim....

$6.27M
USD
Completed NON-SBIR/STTR RPGS
Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2026

Anti-estrogen therapy is key to the prevention and treatment of estrogen receptor (ER, ESR1) positive breast cancer, but therapy resistance occurs in up to a half of cases resultin...

$5.66M
USD
Completed NON-SBIR/STTR RPGS
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

PROJECT SUMMARY The lifetime risk for acquiring colorectal cancer (CRC) is 7%, with an astounding rate of disease recurrence in 32% of newly diagnosed patients after their “success...

$6.17M
USD
Completed NON-SBIR/STTR RPGS
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Chemotherapy induced peripheral neuropathy is a common dose-limiting toxicity that can reduce therapeutic effectiveness and impact quality of life for canc...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Project Abstract Live cell reporters of genetic changes in stiff vs soft surroundings – causes & consequences Solid tumors are often palpably stiff and more constrained in 3D g...

$9.05M
USD
Completed TRAINING, INDIVIDUAL
Exploring the Role of Drp1 in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2024

Abstract - Exploring the Role of Drp1 in Colorectal Cancer. Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Approximately 150,000 new c...

$351.4K
USD
Completed NON-SBIR/STTR RPGS
Targeting Lipid Metabolism in Colorectal Cancer
NATIONAL CANCER INSTITUTE University of Kentucky United States 2021 – 2026

PROJECT SUMMARYMetastasis is the main cause of death from solid tumors including colorectal cancer (CRC). Our long-term goal is to develop more selective therapeutic options to pre...

$3.47M
USD
Completed NON-SBIR/STTR RPGS
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2026

Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma G protein-coupled receptors (GPCRs) represent the larges...

$5.35M
USD
Completed TRAINING, INDIVIDUAL
INVESTIGATING THE ROLE OF HSP90 IN SHAPING THE CONSEQUENCES OF BRCA1 MUTATIONS
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2024

PROJECT SUMMARY Mutations that inactivate DNA repair factors increase genome instability and cancer susceptibility. Predicting the phenotypic effects of mutations is confounded by...

$717.3K
USD
Completed TRAINING, INDIVIDUAL
TRANSCRIPTIONAL REPROGRAMMING OF ESR1 MUTANT BREAST CANCER IN METASTASIS AND TREATMENT RESISTANCE
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2024

Project Summary Up to 1 in 8 women in the United States will develop invasive breast cancer in their lifetime, with 70-80% of cases being estrogen receptor positive (ER+). These ca...

$467.5K
USD
Completed NON-SBIR/STTR RPGS
A Preventive Care Approach to Mitigate the Impact of Pediatric ALL Treatment on Sleep
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2024

Project Summary Over 50% of pediatric cancer patients report problems with their sleep, characterized by insomnia disorder symptoms. This results in considerable physical and psych...

$890K
USD
Completed TRAINING, INDIVIDUAL
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2021 – 2024

Project Summary Resistance to alkylating agents, including monofunctional temozolomide (TMZ) and bifunctional CCNU, remains a major obstacle to improving outcomes for patients with...

$675.8K
USD
Completed TRAINING, INDIVIDUAL
Role of Chromatin Bridges in Activating Innate Immune Signaling following Failed Mitosis
NATIONAL CANCER INSTITUTE Harvard University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Abnormal chromatin structures produced by errors in cell division can cause cell death, propagate genetic instability and, potentially, induce inflammatory...

$108.1K
USD
Completed NON-SBIR/STTR RPGS
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

PROJECT SUMMARY Despite the therapeutic promise of STING agonists in cancer, first in human studies have been hampered by lack of precision therapy and issues with drug delivery. M...

$4.07M
USD
Completed NON-SBIR/STTR RPGS
Harnessing Rare Variants for Tumor Classification
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2024

Abstract This project concerns how to extract clinically actionable information for diagnostic purposes from mutational patterns observed from tumor sequencing panels that are incr...

$3.97M
USD